Showing posts from 2021

Breakthrough or Breakdown? Aducanumab’s Approval by the FDA with Comments from Neurologist Dr. Allan Levey

Aduhelm Puts Patients At The Helm, But At What Cost?

Ethics of Memory Research: The Scientist and Society with Dr. Ashleigh Maxcey

Neuromarketing from Home? The Evolution and Ethics of Consumer Neuroscience Research

April International Neuroethics Society Webinar: Brain Data Governance and Neuroethics  

Is the Law Ready for Emerging Neuroprostheses?